alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Exhibit 32

# CERTIFICATION

The undersigned certify pursuant to 18 U.S.C. § 1350, that:

(1)    The accompanying Quarterly Report on Form 10-Q for
the period ended December 31, 2005, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and

(2)    The information contained in the accompanying
Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:   February 1, 2006

| | /s/   Marti Morfitt                               
| | --------------------------------------------------
| | Marti Morfitt, President & Chief Executive Officer

Date:   February 1, 2006

| | /s/   Samuel E. Reinkensmeyer                                                         
| | --------------------------------------------------------------------------------------
| | Samuel E. ReinkensmeyerVice President of Finance, ChiefFinancial Officer and Treasurer

---
# C_2016038EN.01005401.xml

| 1.2.2016 | EN | Official Journal of the European Union | C 38/54 |
| --- | --- | --- | --- |

1.2.2016

EN

Official Journal of the European Union

C 38/54

---

Order of the General Court of 30 November 2015 — Green Pack v OHIM (greenpack)

(Case T-513/14) (1)

1

((Community trade mark - Refusal of registration - Withdrawal of the application for registration - No need to adjudicate))

(2016/C 038/71)

Language of the case: German

Parties

Parties

Applicant: GreenPack GmbH (Berlin, Germany) (represented by: P. Ruess and A. Doepner-Thiele, subsequently by C. Glasemann, lawyers)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: initially G. Schneider, then by G. Schneider and D. Botis, Agents)

Defendant:

Re:

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 29 April 2014 (Case R2324/2013-1) relating to an application for registration of the word sign greenpack as a Community trade mark.

Operative part of the order

Operative part of the order

| 1. | There is no need to adjudicate on the action. |
| --- | --- |

1.

There is no need to adjudicate on the action.

| 2. | GreenPack GmbH is ordered to pay the costs. |
| --- | --- |

2.

GreenPack GmbH is ordered to pay the costs.

---

(1)  OJ C 303, 8.9.2014.

1

---
EXHIBIT 32.1

CERTIFICATION

I, Brian F. Lavin, President of NTS
Capital Corporation, the general partner of NTS-Properties Associates VII, the general partner
of NTS-Properties VII, Ltd. (the Partnership), certify, pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

|1. |  | The quarterly report on Form 10-Q of the Partnership for the period ended June
               30, 2004 (the Report) fully complies with the requirements of
               Section 13(a) of the Securities Exchange Act of 1934, as amended; and
|-- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. |  | The information contained in the Report fairly presents, in all material
               respects, the financial condition and results of operations of the Partnership.
|-- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Dated: August 16, 2004

/s/ Brian F. Lavin

---

President of NTS Capital Corporation,
General Partner of NTS-Properties Associates VII,
General Partner of NTS-Properties VII, Ltd.

A signed original of this written
statement required by Section 906 has been provided to the Partnership and will be
retained by the Partnership and furnished to the Securities and Exchange Commission or its
staff upon request.
EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In connection  with the  quarterly  report of Avitar,  Inc.  (the  "Company") on
Form10-QSB/A  for the period ending March 31, 2005 as filed with the  Securities
and Exchange Commission on the date hereof (the "Report"), I, Peter P. Phildius,
Chief Executive  Officer of the Company certify,  pursuant to 18 U.S.C.  Section
1350, as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, to
my knowledge, that:

     (1) The Report  fully  complies  with the  requirements  of  Section  13(a)
or15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Date: February 10, 2006

                                                  /s/ Peter P. Phildius
                                                  ---------------------
                                                  Peter P. Phildius Chief
                                                  Executive Officer
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.1640 Antimicrobial susceptibility test powder. ( a ) *Identification.* An antimicrobial susceptibility test powder is a device that consists of an antimicrobial drug powder packaged in vials in specified amounts and intended for use in clinical laboratories for determining in vitro susceptibility of bacterial pathogens to these therapeutic agents. Test results are used to determine the antimicrobial agent of choice in the treatment of bacterial diseases.
( b ) *Classification.* Class II (performance standards).
<PAGE>   1
                                                                 EXHIBIT 10.25

                                1ST AMENDMENT TO
                         EXECUTIVE EMPLOYMENT AGREEMENT

THIS AGREEMENT is made as of the 18th day of August, 1998, between NICHOLAS A.
TILIACOS, a Washington resident ("Executive"), and MOSAIX, INC., a Washington
corporation ("Company").

The parties agree as follows:

1.       AMENDMENT OF PRIOR AGREEMENT.

This Agreement amends that certain "Executive Employment Agreement" dated as of
February 5, 1998 between Executive and the Company. Except as expressly provided
herein, the terms and conditions of that agreement remain in effect between the
parties, and defined terms therein shall have the same meaning when used in this
Agreement.

2.       SEVERANCE PAYMENTS.

Section 8 of the Executive Employment Agreement is hereby amended so that, in
the event Executive terminates his employment for Good Reason, or if the Company
terminates employment without cause following a Corporate Transaction, the
Company shall be obligated to pay to Executive his then regular base salary for
a period of two years after the effective date of termination of employment (as
opposed to 12 months, as originally provided). This amendment will not apply in
the event of any termination unrelated to a Corporate Transaction.

IN WITNESS WHEREOF, the parties have executed and entered into this Agreement as
of the date above first written.

EXECUTIVE:                         COMPANY:

                                   MOSAIX, INC.,
                                   a Washington Corporation


/s/ Nicholas A. Tiliacos           By: /s/ Wm. Bradford Weller
------------------------------         -----------------------------------------
NICHOLAS A. TILIACOS                   Wm. Bradford Weller
                                       Its General Counsel & Assistant Secretary
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.3850 *Trichinella spiralis* serological reagents. ( a ) *Identification. Trichinella spiralis* serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to *Trichinella spiralis* in serum. The identification aids in the diagnosis of trichinosis caused by parasitic roundworms belonging to the genus *Trichinella* and provides epidemiological information on trichinosis. Trichinosis is caused by ingestion of undercooked, infested meat, especially pork, and characterized by fever, muscle weakness, and diarrhea.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.
[47 FR 50823, Nov. 9, 1982, as amended at 65 FR 2312, Jan. 14, 2000]
# C_2016038EN.01005302.xml

| 1.2.2016 | EN | Official Journal of the European Union | C 38/53 |
| --- | --- | --- | --- |

1.2.2016

EN

Official Journal of the European Union

C 38/53

---

Order of the General Court of 30 November 2015 — Gmina Kosakowo v Commission

(Case T-217/14) (1)

1

((Action for annulment - Replacement of the contested act during proceedings - No need to adjudicate))

(2016/C 038/70)

Language of the case: Polish

Parties

Parties

Applicant: Gmina Kosakowo (Kosakowo, Poland) (represented by: M. Leśny, lawyer)

Applicant:

Defendant: European Commission (represented by: D. Grespan, S. Noë and A. Stobiecka-Kuik, acting as Agents)

Defendant:

Intervener in support of the applicant: Republic of Poland (represented by: B. Majczyna, acting as Agent)

Re:

Re:

Application for the annulment of Commission Decision 2014/883/EU of 11 February 2014 on the measure SA.35388 (13/C) (ex 13/NN and ex 12/N) — Poland — Setting up the Gdynia-Kosakowo Airport (OJ 2014 L 357, p. 51).

Operative part of the order

Operative part of the order

| 1. | There is no longer any need to adjudicate on the action. |
| --- | --- |

1.

There is no longer any need to adjudicate on the action.

| 2. | The European Commission shall bear its own costs and shall pay those incurred by Gmina Kosakowo as regards the main proceedings. |
| --- | --- |

2.

The European Commission shall bear its own costs and shall pay those incurred by Gmina Kosakowo as regards the main proceedings.

| 3. | Gmina Kosakowo shall bear its own costs and shall pay those incurred by the Commission as regards the proceedings for interim relief. |
| --- | --- |

3.

Gmina Kosakowo shall bear its own costs and shall pay those incurred by the Commission as regards the proceedings for interim relief.

| 4. | The Republic of Poland shall bear its own costs. |
| --- | --- |

4.

The Republic of Poland shall bear its own costs.

---

(1)  OJ C 202, 30.6.2014.

1

---
- fplr2257-1
- fplr2257-2
- fplr2257-3
- fplr2257-4
- fplr2257-5
- fplr2257-6
- fplr2257-7
- fplr2257-8
- fplr2257-9
- fplr2257-10
- fplr2257-11
- fplr2257-12
- fplr2257-13
- fplr2257-14
- fplr2257-15
- fplr2257-16
- fplr2257-17
- fplr2257-18
- fplr2257-19
- fplr2257-20
- fplr2257-21
- fplr2257-22
- fplr2257-23
**Exhibit 31.1**

 

**CERTIFICATION**

 

I, Robin Raina, certify that:

 

1. I have reviewed thisquarterly report on Form 10-Q of Ebix, Inc.;

 

2. Based on my knowledge, thisreport does not contain any untrue statement of a material fact or omit tostate a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading withrespect to the period covered by this report;

 

3. Based on my knowledge, thefinancial statements, and other financial information included in this report,fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periodspresented in this report;

 

4. The registrant’s othercertifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:

 

(a) Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

 

(b) Evaluated the effectivenessof the registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on suchevaluation; and

 

(c) Disclosed in this reportany change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

 

5. The registrant’s othercertifying officer and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performingthe equivalent functions):

 

(a) All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

 

(b) Any fraud, whether or notmaterial, that involves management or other employees who have a significantrole in the registrant’s internal control over financial reporting.

 

 
| Date:  | May 17, 2004            | /s/ Robin Raina |   |
|--------|-------------------------|-----------------|--------|
|   | Robin Raina             |
|   | Chief Executive Officer |

 

1

----
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.9750 Heat-sealing device. ( a ) *Identification.* A heat-sealing device is a device intended for medical purposes that uses heat to seal plastic bags containing blood or blood components.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 864.9.
[45 FR 60650, Sept. 12, 1980, as amended at 65 FR 2311, Jan. 14, 2000]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

          - [TA-W-70,849]

                    In accordance with Section 223 of the Trade Act of 1974, as amended (“Act”), 19 U.S.C. 2273, the Department of Labor issued a Certification of Eligibility to Apply for Worker Adjustment Assistance on October 22, 2009, applicable to workers of Venta-Airwasher, LLC, Itasca, Illinois. The notice was published in the                     **Federal Register**                     on December 11, 2009 (74 FR 65795).                

At the request of the State Agency, the Department reviewed the certification for workers of the subject firm. The workers provided sales and distribution services for humidifiers and dehumidifiers produced by the subject firm.

The company reports that on-site leased workers from Metro Staffing, Snelling and Office Team were employed on-site at the Itasca, Illinois location of Venta-Airwasher, LLC. The Department has determined that these workers were sufficiently under the control of the subject firm to be considered leased workers.

Based on these findings, the Department is amending this certification to include workers leased from Metro Staffing, Snelling and Office Team working on-site at the Itasca, Illinois location of Venta-Airwasher, LLC.

The amended notice applicable to TA-W-70,849 is hereby issued as follows:

“All workers of Venta-Airwasher, LLC, including on-site leased workers from Metro Staffing, Snelling and Office Team, Itasca, Illinois, who became totally or partially separated from employment on or after May 28, 2008, through October 22, 2011, and all workers in the group threatened with total or partial separation from employment on the date of certification through two years from the date of certification, are eligible to apply for adjustment assistance under Chapter 2 of Title II of the Trade Act of 1974, as amended.”

Signed at Washington, DC, this 19th day of February 2010. 

Michael W. Jaffe,

Certifying Officer, Division of Trade Adjustment Assistance.

[FR Doc. 2010-4577 Filed 3-4-10; 8:45 am]

BILLING CODE 4510-FN-P
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.9275 Blood bank centrifuge for in vitro diagnostic use. ( a ) *Identification.* A blood bank centrifuge for in vitro diagnostic use is a device used only to separate blood cells for further diagnostic testing.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 864.9.
[45 FR 60645, Sept. 12, 1980, as amended at 65 FR 2310, Jan. 14, 2000]
§ 520.1194 Ivermectin meal. ( a ) *Specifications.* Each gram of meal contains 6 milligrams ivermectin (0.6 percent).
( b ) *Sponsor.* See No. 017135 in § 510.600(c) of this chapter.
( c ) *Special considerations.* See § 500.25 of this chapter.
( d ) *Conditions of use in horses* — ( 1 ) *Amount.* Administer 136 micrograms (mcg) ivermectin per pound (/lb) body weight (300 mcg/kilogram) as a single dose on approximately 2 lb grain or sweet feed.
( 2 ) *Indications for use.* For treatment and control of Large Strongyles (adults): *Strongylus vulgaris* (also early forms in blood vessels), *S.* *edentatus* (also tissue stages), *S.* *equinus*, *Triodontophorus* spp. Including *T.* *brevicauda* and *T.* *serratus*, and *Craterostomum acuticaudatum*; Small Strongyles (adults, including those resistant to some benzimidazole class compounds): *Coronocyclus* spp. Including *C.* *coronatus*, *C.* *labiatus*, and *C.* *labratus*, *Cyathostomum* spp. Including *C.* *catinatum* and *C.* *pateratum*, *Cylicocyclus* spp. Including *C.* *insigne*, *C.* *leptostomum*, *C.* *nassatus*, and *C.* *brevicapsulatus*, *Cylicodontophorus* spp., *Cylicostephanus* spp. Including *C.* *calicatus*, *C.* *goldi*, *C.* *longibursatus*, and *C.* *minutus*, and *Petrovinema poculatum*; Small Strongyles (fourth-stage larvae); Pinworms (adults and fourth stage larvae): *Oxyuris equi*; Ascarids (adults and third- and fourth-stage larvae): *Parascaris equorum*; Hairworms (adults): *Trichostrongylus axei*; Large Mouth Stomach Worms (adults): *Habronema muscae*; Bots (oral and gastric stages): G*asterophilus* spp. Including *G.* *intestinalis* and *G.* *nasalis*; Lungworms (adults and fourth-stage larvae): *Dictyocaulus arnfieldi*; Intestinal Threadworms (adults): *Strongyloides westeri*; Summer Sores caused by *Habronema* and *Draschia* spp. Cutaneous third-stage larvae; Dermatitis caused by neck threadworm microfilariae, *Onchocerca* sp. *Limitations.* Do not use in horses intended for human consumption.
[70 FR 1817, Jan. 11, 2005, as amended at 70 FR 19262, Apr. 13, 2005]
EXHIBIT 32

CERTIFICATION PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly
Report of GVC Venture Corp. (the Company) on Form 10-QSB for the quarter ended
September 30, 2006, as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Bernard Zimmerman, Principal Executive Officer and
Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that, to the best of
my knowledge:

|(1) |  | The Report fully complies with the requirements of Section 13(a) or 15(d) of the
               Securities Exchange Act of 1934; and
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the report fairly presents, in all material
               respects, the financial condition and results of operations of the Company.
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------

|                 | 
|---------------- | 
|November 3, 2006 | 
|                 | 
|                 | 
|                 |
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Retirement Thrift Investment Board

# Time and Date:

9 a.m. (Eastern Time), January 19, 2010.

# Place:

4th Floor Conference Room, 1250 H Street, NW., Washington, DC 20005.

# Status:

Parts will be open to the public and parts closed to the public.

# Matters to be Considered:

Parts Open to the Public

1. Approval of the minutes of the November 16, 2009 Board member meeting.

2. Thrift Savings Plan activity report by the Executive Director.

a. Monthly Participant Activity Report.

b. Monthly Investment Performance Report.

c. Legislative Report.

3. Website Re-Design Update.

4. IT Modernization Plan Update.

5. Quarterly Vendor Financial Report.

6. Review of Gross and Net Expense Ratios.

## Parts Closed to the Public

7. Confidential Financial Information.

# Contact Person for More Information:

Thomas J. Trabucco, Director, Office of External Affairs, (202) 942-1640.

Dated: January 7, 2010.

Thomas K. Emswiler,

Secretary, Federal Retirement Thrift Investment Board.

[FR Doc. 2010-441 Filed 1-8-10; 11:15 am]

BILLING CODE 6760-01-P